DiChiacchio Laura, Singh Avneesh K, Chan Joshua L, Shockcor Nicole M, Zhang Tianshu, Lewis Billeta G, Ayares David, Corcoran Philip, Horvath Keith A, Mohiuddin Muhammad M
Department of Surgery, University of Maryland Medical Center, Baltimore, MD, United States.
National Heart, Lung, Blood Institute, National Institute of Health, Bethesda, MD, United States.
Front Cardiovasc Med. 2019 Jul 25;6:95. doi: 10.3389/fcvm.2019.00095. eCollection 2019.
Heterotopic cardiac xenotransplantation in the intra-abdominal position has been studied extensively in a pig-to-baboon model to define the optimal donor genetics and immunosuppressive regimen to prevent xenograft rejection. Extensive investigation using this model is a necessary stepping stone toward the development of a life-supporting animal model, with the ultimate goal of demonstrating suitability for clinical cardiac xenotransplantation trials. Aspects of surgical technique, pre- and post-operative care, graft monitoring, and minimization of infectious risk have all required refinement and optimization of heterotopic cardiac xenotransplantation over time. This review details non-immunologic obstacles relevant to this model described by our group and in the literature, as well as strategies that have been developed to address these specific challenges.
在猪到狒狒的模型中,对腹腔内异位心脏异种移植进行了广泛研究,以确定预防异种移植排斥的最佳供体遗传学和免疫抑制方案。使用该模型进行广泛研究是开发维持生命的动物模型的必要垫脚石,其最终目标是证明适用于临床心脏异种移植试验。随着时间的推移,手术技术、术前和术后护理、移植物监测以及感染风险最小化等方面都需要对异位心脏异种移植进行改进和优化。本综述详细介绍了我们团队和文献中描述的与该模型相关的非免疫障碍,以及为应对这些特定挑战而制定的策略。